Advertisement
UK markets close in 7 hours 54 minutes
  • FTSE 100

    8,128.47
    +49.61 (+0.61%)
     
  • FTSE 250

    19,707.55
    +105.57 (+0.54%)
     
  • AIM

    755.29
    +2.17 (+0.29%)
     
  • GBP/EUR

    1.1651
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2503
    -0.0008 (-0.07%)
     
  • Bitcoin GBP

    51,468.12
    +97.71 (+0.19%)
     
  • CMC Crypto 200

    1,388.36
    -8.17 (-0.59%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.07
    +0.50 (+0.60%)
     
  • GOLD FUTURES

    2,356.90
    +14.40 (+0.61%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,646.84
    +362.30 (+2.10%)
     
  • DAX

    18,012.17
    +94.89 (+0.53%)
     
  • CAC 40

    8,043.89
    +27.24 (+0.34%)
     

European shares trudge higher as stimulus wave stems selloff

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

March 24 (Reuters) - European shares attempted another rebound on Tuesday after slumping in the previous session, as a fresh round of monetary and fiscal stimulus offered some relief even as the coronavirus pandemic spreads rapidly across the globe.

The pan-European STOXX 600 index was up 3% at 0802 GMT, but still set for its worst month since 1987 as the health crisis threatened to crimp global growth, with some analysts seeing a 24% fall in European GDP in the second quarter.

Although investors have largely shrugged off macroeconomic data so far, all eyes will now be on a flash reading of activity surveys from the euro zone due later in the day for signs of the extent of the economic damage from the outbreak.

ADVERTISEMENT

Travel and leisure stocks, which have posted some of the heaviest losses this month, were up 2.6% in early trading.

Miners, insurers and oil and gas stocks were the biggest gainers among the major European subsectors, rising between 5% and 6%.

France's Biomérieux jumped 30% after the healthcare company won approval from the U.S. Food and Drug Administration for its product aimed at testing for coronavirus. (Reporting by Sagarika Jaisinghani in Bengaluru; Editing by Bernard Orr)